Atıf İçin Kopyala
YURTDAŞ KIRIMLIOĞLU G.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, cilt.47, sa.8, ss.1261-1278, 2021 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
47
Sayı:
8
-
Basım Tarihi:
2021
-
Doi Numarası:
10.1080/03639045.2021.1989452
-
Dergi Adı:
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Biotechnology Research Abstracts, Business Source Elite, Business Source Premier, CAB Abstracts, Chemical Abstracts Core, EMBASE, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
-
Sayfa Sayıları:
ss.1261-1278
-
Anahtar Kelimeler:
Cefpodoxime proxetil, 2-hydroxypropyl-beta-cyclodextrin, methyl-beta-cyclodextrin, inclusion complex, antibacterial activity, dissolution, solubility, spray drying, hard cellulose capsules, DRUG-DELIVERY SYSTEMS, IN-VITRO EVALUATION, PHYSICOCHEMICAL CHARACTERIZATION, ANTIMICROBIAL ACTIVITY, AQUEOUS-SOLUTION, 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN PREPARATION, POLYMERIC NANOPARTICLES, BINDING BEHAVIORS, VIVO EVALUATION, CD PREPARATION
-
Anadolu Üniversitesi Adresli:
Evet
Özet
Objective: The aim of the current research was the development hard cellulose capsules containing cefpodoxime proxetil (CEF) (BCS-Class II) encapsulated nanospheres of inclusion complexes with beta-CD, HP-beta-CD and M-beta-CD for efficient antibacterial therapy.